Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis

$259,704R01FY2020AINIH

Ohio State University, Columbus OH

Investigators

Meihong Dengcontact

Linked publications & trials

Paper 36278484 Paper 35401237 Paper 34127858 Paper 34048015 Paper 33710107 Paper 33320841 Paper 32967837

View original record on NIH RePORTER →

Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis · GrantIndex